O. Calatayud et al., CAFFEINE TEST ASSESSMENT FOR MEASURING LIVER-FUNCTION IN CRITICALLY ILL PATIENTS, Journal of clinical pharmacy and therapeutics, 20(1), 1995, pp. 23-29
Caffeine elimination was studied in 73 patients admitted to an intensi
ve care unit, 33 of whom had liver disease. Mean plasma clearance of c
affeine in patients with no liver disease (1.30 +/- 0.79 ml/kg/min) wa
s significantly higher than in patients with liver disease (0.39 +/- 0
.23 ml/kg/min). Mean half-life of caffeine in patients with liver dise
ase (23.96 +/- 12.19 h) was significantly higher than in patients with
no liver disease (7.25 +/- 3.04 h). No significant differences in dis
tribution volumes were found. Receptor-operator curves (ROC) for plasm
a clearance and the half-life of elimination of caffeine showed a high
diagnostic value. Therefore, the parameters for caffeine biotransform
ation, i.e. Cl and t(1/2), are useful for assessing liver function in
the population studied.